Department of Anesthesia and Intensive Care, Helsingborg Hospital, Helsingborg, Sweden.
Department of Intensive Care Medicine, Laboratory of Experimental Intensive Care and Anesthesiology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, 1105 AZ, The Netherlands.
Crit Care. 2018 Aug 18;22(1):196. doi: 10.1186/s13054-018-2119-5.
Dyscarbia is common in out-of-hospital cardiac arrest (OHCA) patients and its association to neurological outcome is undetermined.
This is an exploratory post-hoc substudy of the Target Temperature Management (TTM) trial, including resuscitated OHCA patients, investigating the association between serial measurements of arterial partial carbon dioxide pressure (PaCO) and neurological outcome at 6 months, defined by the Cerebral Performance Category (CPC) scale, dichotomized to good outcome (CPC 1 and 2) and poor outcome (CPC 3-5). The effects of hypercapnia and hypocapnia, and the time-weighted mean PaCO and absolute PaCO difference were analyzed. Additionally, the association between mild hypercapnia (6.0-7.30 kPa) and neurological outcome, its interaction with target temperature (33 °C and 36 °C), and the association between PaCO and peak serum-Tau were evaluated.
Of the 939 patients in the TTM trial, 869 were eligible for analysis. Ninety-six percent of patients were exposed to hypocapnia or hypercapnia. None of the analyses indicated a statistical significant association between PaCO and neurological outcome (P = 0.13-0.96). Mild hypercapnia was not associated with neurological outcome (P = 0.78) and there was no statistically significant interaction with target temperature (P = 0.95). There was no association between PaCO and peak serum-Tau levels 48 or 72 h after return of spontaneous circulation (ROSC).
Dyscarbia is common after ROSC. No statistically significant association between PaCO in the post-cardiac arrest phase and neurological outcome at 6 months after cardiac arrest was detected. There was no significant interaction between mild hypercapnia and temperature in relation to neurological outcome.
低碳酸血症在院外心脏骤停(OHCA)患者中很常见,但其与神经功能预后的关系尚不确定。
这是目标温度管理(TTM)试验的一项探索性事后亚研究,纳入了复苏后的 OHCA 患者,研究了动脉血部分二氧化碳分压(PaCO)的连续测量值与 6 个月时神经功能预后(以脑功能预后分类(CPC)量表定义,分为良好预后(CPC 1 和 2)和不良预后(CPC 3-5))之间的关系。分析了高碳酸血症和低碳酸血症的影响,以及时间加权平均 PaCO 和绝对 PaCO 差值。此外,还评估了轻度高碳酸血症(6.0-7.30 kPa)与神经功能预后的关系、其与目标温度(33°C 和 36°C)的交互作用,以及 PaCO 与血清 Tau 峰值之间的关系。
在 TTM 试验的 939 例患者中,869 例符合分析条件。96%的患者存在低碳酸血症或高碳酸血症。PaCO 与神经功能预后之间的任何分析均无统计学显著相关性(P 值为 0.13-0.96)。轻度高碳酸血症与神经功能预后无关(P=0.78),与目标温度之间也无统计学显著交互作用(P=0.95)。在自主循环恢复(ROSC)后 48 或 72 小时,PaCO 与血清 Tau 峰值之间无关联。
ROSC 后低碳酸血症很常见。在心脏骤停后阶段 PaCO 与心脏骤停后 6 个月时的神经功能预后之间未发现统计学显著相关性。轻度高碳酸血症与温度之间的神经功能预后无显著交互作用。